Prevention of recurrent attacks of hereditary angioedema
Adult: Initially, 300 mg every 2 weeks. In patients who are well-controlled (e.g. attack free) for >6 months: 300 mg every 4 weeks. Dosing recommendations may vary among individual products and between countries (refer to specific product guidelines).
Child: ≥12 years Same as adult dose.
Child: ≥12 years Same as adult dose.